IPO registrations (S-1, F-1) · Registrants

KalVista Pharmaceuticals, Inc.

SEC CIK

1348911 · filings on EDGAR ↗

Name on the registration

Carbylan Therapeutics, Inc.

Former names

Carbylan Therapeutics, Inc. (2014–2016); Carbylan Biosurgery, Inc (2013–2013); Carbylan Biosurgery Inc (2005–2005)

Registration

Form S-1, first filed 2014-12-29, last 2015-04-06; 1 initial registration, 2 amendments

Outcome

Final prospectus filed 2015-04-09; declared effective 2015-04-08

Industry (SIC)

Pharmaceutical Preparations 2834

Incorporated in

DE

Business address

200 CROSSING BOULEVARD, Framingham, MA 01702

EIN

20-0915291

EDGAR entity type

operating

Insiders and CEO pay

KalVista Pharmaceuticals, Inc. on the corporate pages

Offering terms

Final price

$5.00 per share (424B4 filed 2015-04-09, an initial public offering)

Shares sold

13,000,000

Gross proceeds

$65,000,000 before underwriting discounts and any over-allotment option

Listing

Nasdaq under the symbol CBYL

Lead underwriters

Leerink Partners

Syndicate

JMP Securities; Wedbush Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

• Business registration: KAL VISTA PHARMACEUTICALS, INC. EXACT (EIN (EXACT, as the state registration reports it))
• Business registration: Kalvista Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: KalVista Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: KalVista Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: KalVista Pharmaceuticals, Inc. Fuzzy (name and state)
• Business registration: KALVISTA PHARMACEUTICALS, INC. Fuzzy (name and state)
• Business registration: KALVISTA PHARMACEUTICALS, INC. Fuzzy (name and state)
• Business registration: KALVISTA PHARMACEUTICALS, INC. Fuzzy (name and state)
• Business registration: KALVISTA PHARMACEUTICALS, INC. Fuzzy (name and state)
• Form 5500 plan sponsor: KALVISTA PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
• Form D issuer: Carbylan Therapeutics, Inc. EXACT (CIK (EXACT))
• SEC filer: Carbylan Therapeutics, Inc. EXACT (CIK (EXACT))

Filings 7

Prospectus pages read 2

Officers, directors and large holders Forms 3, 4 and 5

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

• ERGO SCIENCE CORP MA
• MILLENNIUM PHARMACEUTICALS INC MA
• ESSENTIAL THERAPEUTICS INC MA
• ARQULE INC MA
• ASCENT PEDIATRICS INC MA
• EPIX Pharmaceuticals, Inc. MA
• PRAECIS PHARMACEUTICALS INC MA
• PARATEK PHARMACEUTICALS INC MA
• PREDIX PHARMACEUTICALS HOLDINGS INC MA
• CervoMed Inc. MA

More with this interest.

In other datasets, the same topic (Health) in MA:

• Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))

Interests: Pharmaceutical Preparations · Health